1Chen S,Chen CM,Zhou Y,et al.Obesity or Overweight Is Associaed with Worse Pathological Response to Neoadjuvant Chemotherapy mong Chinese Women with Breast Cancer[J].PLoS One, 2012,7(7)=e41580.
28dnchez-govira P,Ant6n A,Ba#nadas A,et al. Olassical markers like EE and ki-67, but also survivin and pEEK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in Iocally advanced breast cancer patients, results from the GEiQAM/2002-O] phase il study[J]. Olin TPansl 0ncol,2012,i4(6).450-456.
6Dooley WG,Algan a prospective and adjuvant World J 8urg nonrandomized O,Dowlatshah . multicenter electronic brachytherapy for 0ncol.2011.9.30. K,et ai.Surgica; perspectives from study of breast conserving surgery the treatment of breast cancer[J].World J Surg 0ncol,2011,9.50.
7Chen K,Jia W,Li ,et aI.Cavity margin status is an independent risk factor for local-regional recurrence in breast cancer patients treated with neosdjuvant chemotherapy before breast-conserving surgery[J]. Am Surg, 2011,77(12):1700-1706.
9Narendra H,ay S.Breast conserving surgery for breast cancer: single institutional experience from Southern India[J].lndian d Cancer, 2011,48(4):415--422.
10Downey L,Livingston R,Stopeck A.Diagnosing and treating breast cancer in elderly women:a call for improved understanding[J].Am Geriatr Soc,2007,55(10):1636-1644.
